Immunotherapy versus radiation after surgery for head and neck cancer
Treatments studied
Part of Cancer clinical trials.
This trial compares two different treatments for people who have already had surgery for advanced head and neck cancer and responded very well to chemotherapy plus immunotherapy before surgery. It tests whether continuing with immunotherapy or receiving radiation therapy is better at preventing the cancer from coming back.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had surgery for head and neck cancer (stage III–IV) and the removed tissue showed at least 90% of the cancer cells were gone (a major response).
- You received immunotherapy and chemotherapy before the surgery.
- You are between 18 and 75 years old.
- You have no history of other cancers.
- Your blood tests, heart, liver, kidney, and thyroid function are within safe limits.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at whether giving an immunotherapy drug (a PD-1 inhibitor) after surgery is better than giving radiation therapy for people with advanced head and neck cancer who had a complete response to chemotherapy and immunotherapy before surgery. The goal is to prevent the cancer from coming back.
This trial tests whether 2 or 4 cycles of pembrolizumab (immunotherapy) plus carboplatin and nab-paclitaxel (chemotherapy) before surgery works better for people with advanced head and neck cancer that can be removed. The goal is to see if fewer treatments are just as effective.
This trial compares two different treatments after surgery for advanced head and neck cancer (oral or oropharyngeal). It tests whether radiation therapy or continuing an immunotherapy drug (called PD-1 inhibitor) leads to better survival. This study might help you decide which follow-up treatment could be better for your situation.
This trial compares a less extensive surgery to the standard surgery for patients with advanced head and neck cancer who have responded well to initial chemotherapy and immunotherapy. The goal is to see if a smaller operation can be just as effective while causing fewer side effects.
This trial compares giving immunotherapy alone versus immunotherapy plus focused radiation before surgery for head and neck cancer. The goal is to see if adding radiation helps shrink the tumor and improve outcomes.
This Phase 2 study looks at what treatment is best after you first receive chemotherapy plus immunotherapy, then have surgery for head and neck squamous cell cancer. It tries to use how your tumor responds (shown in lab tissue after treatment) to guide the next steps, which may improve outcomes.
Hear when a new HNSCC trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.